Green Valley Investors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-208,487
Closed -$49.8M 30
2017
Q1
$49.8M Sell
208,487
-730
-0.3% -$170K 2.45% 16
2016
Q4
$43.9M Sell
209,217
-16,943
-7% -$3.51M 2.31% 17
2016
Q3
$52.1M Sell
226,160
-81,357
-26% -$19.9M 2.67% 15
2016
Q2
$71.1M Sell
307,517
-59,921
-16% -$13.8M 2.17% 18
2016
Q1
$98.5M Sell
367,438
-32,562
-8% -$9.32M 2.41% 16
2015
Q4
$125M Hold
400,000
2.56% 16
2015
Q3
$109M Buy
+400,000
New +$123M 2.33% 17

Other funds holding AGN

Green Valley Investors's AGN Position: Q2 2017 in Review

Green Valley Investors sold out of Allergan plc (AGN) in Q2 2017, closing a stake of 208,487 shares — an estimated $49.8M sold.

Green Valley Investors first reported a position in AGN in Q3 2015 and held it in 7 quarters. The position peaked at $125M in Q4 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.

  • Green Valley Investors reported no remaining Allergan plc position as of Q2 2017 after selling out during the quarter.
  • Green Valley Investors sold 208,487 Allergan plc shares in Q2 2017, an estimated $49.8M.
  • Green Valley Investors first reported a position in Allergan plc in Q3 2015 and held it in 7 quarters.
  • Green Valley Investors's Allergan plc position peaked at $125M in Q4 2015.
  • 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.

Based on Green Valley Investors's 13F filing for Q2 2017, filed 10 Aug 2017.